Health
Americans Are Microdosing Obesity Drugs, Driven by 'Thin Is In' Marketing Blitz
Telehealth companies are aggressively marketing GLP-1s as cosmetic elixirs for anyone who wants to lose a few pounds.
Loosely regulated online platforms are promoting powerful obesity shots as a universal weight-loss solution.
Photographer: Leafy Yun Ye/Bloomberg
Weight-loss drugs are coming for a new kind of customer.
“You don’t need to be obese to start a GLP-1,” reads an ad from a telehealth startup, the words scrawled in icing on a cake. Another one features a slender woman excited to lose a little weight before her wedding. Yet another says patients can drop 17 pounds in two months by microdosing copycat Ozempic.